Nymox Pharmaceutical Corporation
Advertisement
Nymox Pharmaceutical Corporation, based in Saint-Laurent, QC, is dedicated to developing innovative therapies for men suffering from Benign Prostate Hyperplasia (BPH). The company is focused on introducing a new, safe, and effective injectable treatment that selectively targets prostate gland cells.
With ongoing research into Fexapotide for BPH and low-grade localized prostate cancer, Nymox is committed to advancing medical science and improving patient outcomes. The company also engages in scientific publications and maintains a pipeline of products aimed at addressing various health concerns.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.
Advertisement